Enlargement Directorate-General


Screening Chapter 25 on Science & Research

Turkey and Croatia

Explanatory Meeting

Brussels, 20 October 2005
Venue: CHAR S1


Annotated Agenda


Community Legislation on “Science, Information, Education and Culture”




Research Policy and European Research Area


        Communication of the Commission on 18 January 2000 “Towards a European Research Area”, which aims at contributing to a better overall framework condition for research in the European Union [Celex: 52000DC0006, COM (2000) 6]


Sixth EC Framework Programme including specific programmes and rules of participation


        Decision N°1513/2002/EC of the European Parliament and of the Council adopted on 27 June 2002 (see OJ L 232, p1 of 29/08/02, Celex: 02002D1513-20040430) concerning the Sixth Framework Programme for research, technological development and demonstration activities, contributing to the creation of the European Research Area and Innovation (2002-2006) ( Research and technological development);


        Council Decision N°2002/834/EC of 30/09/02, adopting a specific programme for research, technological development and demonstration “Integrating and strengthening the European Research Area (2002-2006) (see OJ L 294/1 of 29/10/02, Celex: 32002D0834) ( Research and technological development);

        Council decision N°2002/835/EC of 30/09/02, adopting a specific programme for research, technological development and demonstration “Structuring the European Research Area (2002-2006) (see OJ L 294, p 44 of 29/10/02, Celex: 32002D0835) ( Research and technological development);

        Council Decision Nº2002/837/Euratom of 30/09/02 adopting a specific programme (Euratom) for research and training needs in energy (2002-2006) (see OJ L294, p 74 of 29/10/02, Celex: 32002D0837) ( Nuclear Research);

        Regulation (EC) N° 2321/2002 of the European Parliament and of the Council adopted on 16 December 2002 concerning the rules for the participation of undertakings, research centres and universities and for the dissemination of research results for the implementation of the European Community Sixth Framework Programme (2002-2006) (see OJ L 355, p 23 of 30/12/02, Celex: 32002R2321) (13.10.30. Research and technological development) and

        Regulation (Euratom) N°2322/2002 of the European Parliament and of the Council adopted on 5 November 2002 concerning the rules for the participation of undertakings, research centres and universities and for the dissemination of research results for the implementation of the Sixth Framework Programme of the European Atomic Energy Community (see OJ L 355, p.35 of 30/12/02, Celex: 32002R2322) ( Nuclear Research; Research and technological development).

DG Joint Research Centre Activities (direct actions)


        Council Decision 2002/836/EC of 30 September 2002 adopting the specific programme of research, technological development and demonstrative activities to be carried out by direct actions (Celex: 32002D0836) ( Research and technological development);

        Council Decision 2002/838/Euratom for the JRC/Euratom activities (Celex: 32002D0838) ( Nuclear Research).  

International S&T Cooperation Agreements


       International Cooperation Agreements of the EC with third countries on S&T, sorted under Directory of Community Legislation 16.10 Science, 16.10.10 General Principles and 16.10.20 Research Sectors.


Action Plan 3%: increase investment in research


        Commission Communication COM (2003) 226 final/2 (Celex: 52003DC0226R(01)) "Investing in research: an action plan for Europe" (see ( General Principles of Research and technological development);

        Commission Communication COM (2005) 488 final adopted on 12 October 2005 on “More research and innovation: investing for growth and employment - A common approach” (see and

        Council Recommendation on the Broad Guidelines for the Economic Policy (BEGP) endorsed by the Ecofin Council [The Economic and Financial Affairs Council] and the European Council (soon to be formally adopted); see in particularly guideline 7 confirming the overall 3% objective (see

        (For “More Research for Europe: Towards the 3% of GDP” see


Advisory Bodies: Crest


        Council Resolution of 28 September 1995 on Crest [Scientific and Technical Research Committee] (see OJ C 264, p4 of 11/10/95);


Article 169(*) initiative


        Decision N° 1209/2003/EC of the European Parliament and the Council of 16 June 2003 on “Community participation in a research and development programme aimed at developing new clinical interventions to combat HIV/AIDS, malaria and tuberculosis through a long-term partnership between Europe and developing countries, undertaken by several Member States”, OJ L 169, P.1 of 08/07/2003 (Celex: 32003D1209) ( Development Policy, General)


Mobility Action Plan: facilitating movement of researchers


        Communication Recommendation on the European Charter for Researchers and on a Code of Conduct for the Recruitment of Researchers [C (2005) 576 final, OJ L75, p 67 of 22.03.2005, Celex 32005H0251]

( General Principles of Research and technological development) and

        Legislative package adopted on 28 September and 12 October 2005 consisting of a Council Directive setting out specific procedure for admitting third country nationals for scientific research and two Recommendations addressed to Member States aiming at facilitating the entry and residence for researchers.

Action Plan Science and Society


        Action Plan on Science and Society, adopted on 4 December 2001 (see COM (2001) 714;

        Council Resolution 8565/99 of 20 May 1999 (“Women and Science”) ;

        White Paper on European Governance as adopted by the Commission, adopted on 25 July 2001 (see COM 2001/428 final)

        Ethical rules applicable to the Sixth Framework Programme and its implementing provision (see Council minutes of 4 October 2002, 12739/02, RECH156;;

Other Actions

        Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions: Life sciences and biotechnology – A Strategy for Europe; 23.1.2002 COM (2002) 27 final;

[See Annex]

Third progress report and future orientations on the Life Sciences and Biotechnology – A strategy for Europe, 29.06.2005 COM(2005) 286 final, SEC(2005)850   

        Regulation (EC) N° 1728/74 of the Council adopted on 27 June 1974 concerning the coordination of agricultural research. The Standing Committee for Agricultural Research is a mechanism of open coordination between member states and the Commission in agricultural research (Celex: 31974R1728)

(03.30.50 Agricultural Research)

        European Research Fund for Coal and Steel.

The legal basis of the  'Research Programme of the Research Fund for Coal and Steel' is outlined in the Council Decision 2003/76/EC, 2003/77/EC, 2003/78/EC of 1 February 2003, published in the Official Journal of 5 February 2003 ref. OJ L 29/22, OJ L 29/25, OJ L 29/28. See





Information note on

Life Sciences & Biotechnology a Strategy for Europe

20 October 2005


Following a request from the European Council[1] , the Commission adopted in January 2002 “Life sciences and biotechnology – A strategy for Europe” (COM(2002)27 -23 January 2002). The strategy has been developed with the aim of bringing coherence to policy-making, which in Europe is characterised by diverse economic, social and environmental concerns. The strategy seeks to address these concerns comprehensively and coherently and sets out a strategic vision for this area up to 2010, to allow Europe to benefit from the positive potential of life sciences and biotechnology in healthcare, agriculture, food production and environmental protection, to ensure proper governance and to meet Europe’s global responsibilities.

The strategy consisting of two parts – policy orientations and a 30-points action  plan for concrete short, medium and long term measures, to be carried out by Commission, Member States, as well as recommendations for other public and private actors, respecting the subsidiarity principles.

The strategy has four pillars:

Harvesting the potential - Aiming at developing skills, support European research, providing a strong European intellectual property system, increasing access to capital, networking all the various actors working in biotechnology in Europe and increasing the proactive role of the public authorities.

Responsible policy at governing life sciences and biotechnology - Including dialogue among stakeholders, ethical and social implications, consumer’s right to choose and the legislative framework.

Europe in the World – responding to global challenges - Highlighting Europe’s role in developing international guidelines standards and recommendations based on international scientific consensus, and indicate the areas where Europe can support the developing world in its efforts. Europe has a particular responsibility to support developing countries in dealing with the risks, challenges and opportunities, and to facilitate the safe and orderly development of these new technologies at the global level, in accordance with the choice of individual countries.

Implementation and coherence across policies, sectors and actors- Focussing on the role of the European Commission in evaluating and further developing the European biotechnology policy in the coming years.

The European Commission has set up an internal coordination body - the Biotechnology Steering Committee - in order to monitor progress in policy development and to anticipate emerging issues in this fast-developing area.

On 29 June 2005, the Commission presented its third progress report and future orientations on the Life Sciences and Biotechnology – A strategy for Europe (COM(2005) 286, SEC(2005)850), which highlighted the progress made but also pointed out delays and obstacles in some areas.

As depicted in the third progress report, several steps towards fulfilling the goals of the biotechnology strategy have been taken, e.g.: setting up networks and advisory groups with Member States and industry[2], carrying out a benchmarking exercise on national biotechnology policies[3], launching an ambitious cost-benefit analysis of the whole biotechnology sector, pushing for the implementation of the directive 98/44 on the legal protection of biotechnological inventions and proposing a Community Patent Regulation, encouraging a stronger networking of biotechnology clusters in Europe, supporting research under the 6th Framework Programme for research , putting forward the proposals for the 7th Framework Programme for Research and  the Competitiveness and Innovation Programme, taking initiatives to increase investments into and access to capital for biotech companies, continuing the effort to  draw together the innovation triangle: science, society and economy, the reviewing pharmaceutical legislation, implementing balanced European legislation on GMOs and pushing for coherent implementation in all Member States.

Some legislation is under preparation, such as the introduction of labelling thresholds on for the adventitious presence of authorised GM seeds in seeds of conventional and organic varieties, legislation on human tissue engineered products, and legislation on the protection of worker’s personal data as regards genetic testing. Furthermore, the Commission has taken initiatives in collaboration with Member States to ensure the highest quality of genetic testing in the EU and beyond[4].

The Sixth Framework Programme (2002-2006)[5] is continuing to give a strong impetus to Life Sciences and Biotech research in Europe, in particular in terms of critical mass of human and financial resources, sharing of knowledge and facilities, strengthening of scientific excellence, co-ordination of national activities and support to EU policies. The establishment of technology platforms[6], an innovation in EU research policy, has fostered a new public-private partnership. Eight technology platforms in Life Sciences and Biotechnology have been launched respectively on   Innovative Medicines, Industrial Biotechnology (part of the TP on sustainable chemistry), Global Animal Health, Nanomedicine, Food for Life, Forestry-based sector, Farm animal breading. It is expected that these industry driven platforms will play an important role in the research priority setting in FP7 in order to ensure that our efforts are focused on potential future markets. It is also expected that the research agendas and action plan developed by the platforms will have their impact at national and regional level. The implementation of joint technology initiatives is a way of going further in such public-private partnerships. One example in preparation is in the area of innovative medicines. Other initiatives may be launched in the biotech sector in the coming years.

Life Sciences and biotechnology research for medical applications will remain an important priority in the collaboration programme under the   theme “Health” in the Seventh Framework Programme[7]. But FP7 is also expected to give a major impetus to food, agriculture, marine, industrial and environmental biotechnology under the theme “Food, Agriculture and Biotechnology”. It is the intention of the Commission to bring together the relevant technologies and sectors to develop a European Knowledge Based Bio-Economy (KBBE)[8]. A conference “Towards a knowledge based bio-economy in Europe” took place 15-16 September 2005[9]. As a follow-up of this conference the Commission intends to establish a network of officials from across Europe on the Knowledge Based Bio-economy in order to stimulate a coordinated effort in the development and implementation of a European research and innovation policy in this area. The European Research Council is expected to enhance the basic knowledge in life sciences and biotechnology and specific measures will be provided to encourage SME participation , international cooperation and mobility and training of researchers. Support for the establishment of infrastructures and region of knowledge will be provided.

Since 2002, the Commission has progressed with much of its own actions, but a more active cooperation from all Member States in the implementation is needed at the political level to secure the objectives of the biotechnology strategy.

The new Commission has re-launched the Lisbon strategy and aims at making Europe a competitive knowledge-based economy. To do this, biotechnology should play an important part. It is an economically and strategically important area and should be given priority in our efforts to fulfil the Lisbon objectives.

The strategy will undergo a thorough mid-term review in 2006-2007, based on the results of on-going studies (an ambitious cost-benefit study carried out by the JRC in Seville). The mid-term review will include a stocktaking of the achievements and the latest developments, the identification of obstacles, and the setting of new priorities for action together with Member States and the stakeholders.

The time frame for the mid-term review is to report back to the autumn Competitiveness Council in 2006 and the spring European Council in 2007.

Member States are encouraged to contribute actively to the mid-term review, notably by:

        identifying further action priorities together with the Commission,

        committing themselves to realise action priorities timely,

        providing national plans for the implementation of the strategy.

The Commission services will take up the collaboration with Member States for the review in the informal biotechnology contact network of Member State officials. The network with officials on the knowledge-based bio-economy (KBBE) is also expected to contribute to this exercise, in co-ordination with the Standing Committee on Agricultural Research.


(*) Article 169: In implementing the multi annual framework programme, the Community may make provision, in agreement with the Member States concerned, for participation in research and development programmes undertaken by several Member States, including participation in the structures created for the execution of those programmes.


[1] Presidency Conclusion, European Council 23-24 March 2001 in Stockholm 

“Highlights the importance of research, entrepreneurship... Identifies biotechnology as a frontier technology … and requests the Commission, together with the Council, to examine measures required to utilise the full potential of biotechnology and strengthen the European biotechnology sector's competitiveness”


[2] the full text of the Group’s report is available at







[8] We understand the term « bio-economy » as including all industries and economic sectors that produce, manage and otherwise exploit biological resources (such as agriculture, food, forestry, fisheries, health) and related services, supply or consumer  industries.